by chris | Oct 26, 2026 | Uncategorized
Originally posted to PR Newswire At Rosalind Franklin University’s Helix 51 biomedical incubator, an experimental Zika virus-based therapy for glioblastoma is moving closer to potential human clinical trials. NORTH CHICAGO, Ill., Oct. 19, 2026 /PRNewswire/...
by chris | May 27, 2026 | blog, press release
How a Conversation Over Dinner Might Change the Way Brain Cancer Is Treated | UP Oncolytics UP Oncolytics Science Pipeline Team Blog Contact Founding Story Brain Tumor Awareness Month · May 2026 How a ConversationOver Dinner Might Changethe Way Brain...
by chris | May 27, 2026 | blog, press release
Glioblastoma Has Defied Treatments. It's Time for a Radically Different Approach | UP Oncolytics UP Oncolytics Science Pipeline Team Blog Contact Science & Standard of Care April 2026 Glioblastoma Has Defied Treatments.It's Time for a Radically Different Approach...
by chris | May 27, 2026 | blog, press release
A Nurse's Question and the Science It Started | UP Oncolytics UP Oncolytics Science Pipeline Team Blog Contact Regulatory Milestone Rare Disease Day 2026 · Reflecting on October 2024 From Outbreak to Orphan:Reflecting on Our FDA Designation Rare Disease Day is an...
by chris | May 27, 2026 | blog, press release
America's Seed Fund: The SBIR Program and the Future of Biotech Innovation | UP Oncolytics UP Oncolytics, Inc. — Blog Innovation · Science · Policy America's Seed Fund: The SBIR Program and the Future of Biotech Innovation For over four decades, the Small Business...